Holen Sie sich die Stockscreener-App
1.50
3.85%
-0.06
Vorhandelsmarkt:
1.48
-0.02
-1.33%
Schlusskurs vom Vortag:
$1.56
Offen:
$1.53
24-Stunden-Volumen:
217.96K
Relative Volume:
0.08
Marktkapitalisierung:
$48.42M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.14M
KGV:
-2.7778
EPS:
-0.54
Netto-Cashflow:
$-3.99M
1W Leistung:
-4.46%
1M Leistung:
+7.14%
6M Leistung:
-42.08%
1J Leistung:
-64.71%
1-Tages-Spanne:
$1.50
$1.55
1-Wochen-Bereich:
$1.49
$1.5798
52-Wochen-Spanne:
$1.12
$7.0791
Telomir Pharmaceuticals Inc Stock (TELO) Company Profile
Firmenname
Telomir Pharmaceuticals Inc
Sektor
Branche
Telefon
786-396-6723
Adresse
100 SE 2ND ST, MIAMI
Vergleichen Sie TELO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELO
Telomir Pharmaceuticals Inc
|
1.50 | 52.78M | 0 | -16.14M | -3.99M | -0.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-21 | Eingeleitet | Rodman & Renshaw | Buy |
Telomir Pharmaceuticals Inc Aktie (TELO) Neueste Nachrichten
Sentiment analysis tools applied to Telomir Pharmaceuticals Inc.Portfolio Update Report & Reliable Price Breakout Alerts - newser.com
Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio chartsTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
Has Telomir Pharmaceuticals Inc. found a price floorJuly 2025 Outlook & Comprehensive Market Scan Reports - newser.com
How Telomir Pharmaceuticals Inc. stock reacts to global recession fears2025 Valuation Update & Weekly High Return Opportunities - newser.com
Why Telomir Pharmaceuticals Inc. stock attracts global investorsJuly 2025 Trends & Community Consensus Picks - newser.com
What technical models suggest about Telomir Pharmaceuticals Inc.’s comeback - newser.com
Will Telomir Pharmaceuticals Inc. rebound enough to break evenFed Meeting & Proven Capital Preservation Methods - newser.com
Market reaction to Telomir Pharmaceuticals Inc.’s recent newsProduct Launch & Stepwise Trade Signal Implementation - newser.com
Forecasting Telomir Pharmaceuticals Inc. price range with options data2025 Trading Recap & Verified Swing Trading Watchlists - newser.com
Telomir Pharmaceuticals Inc. (TELO) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
What insider trading reveals about Telomir Pharmaceuticals Inc. stockWeekly Stock Recap & Weekly High Return Forecasts - newser.com
What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Analyst Downgrade & Weekly Setup with ROI Potential - newser.com
Combining price and volume data for Telomir Pharmaceuticals Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Telomir Pharmaceuticals Reports Discovery That Telomir-1 Selectively Kills Aggressive Triple-Negative Breast Cancer Cells - Cincinnati Enquirer
Telomir Pharmaceuticals Inc. stock chart pattern explainedJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
Momentum divergence signals in Telomir Pharmaceuticals Inc. chartVolume Spike & AI Driven Price Forecasts - newser.com
Does Telomir Pharmaceuticals Inc. show high probability of reboundQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
Will Telomir Pharmaceuticals Inc. stock benefit from AI adoptionMarket Volume Report & Capital Protection Trade Alerts - fcp.pa.gov.br
Finanzdaten der Telomir Pharmaceuticals Inc-Aktie (TELO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):